Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00493792 · ClinicalTrials.gov registry record · NA
X-3 Polyethylene Survival Outcomes Study
A NA study of Arthroplasty, Replacement, Knee and Total Knee Replacement, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 518
- Enrollment target
- 3
- Study locations
NCT00493792: Completed NA study of Arthroplasty, Replacement, Knee and Total Knee Replacement, sponsored by Mayo Clinic.
NCT00493792 is a NA study of Arthroplasty, Replacement, Knee and Total Knee Replacement that has completed, run by Mayo Clinic. The registered enrollment target is 518 participants, above the 159-participant average among 12 other Arthroplasty, Replacement, Knee trials with a reported enrollment target (226% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00493792, a NA study of Arthroplasty, Replacement, Knee and Total Knee Replacement, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 518 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this clinical trial is to compare two types of polyethylene (Stryker Orthopaedics N2Vac and their X3 polyethylene) prostheses that are used in total knee replacements. The primary outcome will analyze whether or not prostheses require a revision surgery 10 years post knee replacement. Other outcomes such as reoperation rate, complications, radiographic results, and clinical outcomes will be collected. It is hypothesized that X3 would perform equally well to N2Vac at 10 years.
Primary Outcome
The survival of prostheses free of revision 10 years post operation.
Conditions Studied
Interventions
- DEVICE X3 Polyethylene
- DEVICE N2Vac Polyethylene
Study Locations (3)
Arizona
- Mayo Clinic - Phoenix
Florida
- Mayo Clinic - Jacksonville
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 518 participants |
| Start Date | 2007-02 |
| Est. Completion | 2023-11-01 |
| Phase | NA |
What the finished NCT00493792 record still lists
NCT00493792 is an interventional study that assigns participants to a tested intervention. The registered 518 participants enrollment target is mid-sized for trials with a published cap, above the 159-participant average among 12 other Arthroplasty, Replacement, Knee trials with a reported enrollment target (226% higher).
The record links to 2 conditions, with Arthroplasty, Replacement, Knee appearing as the primary indexed condition, and to 2 interventions - of which X3 Polyethylene is the first listed.
NCT00493792 reports a single indexed study location in Arizona, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT00493792 about?
NCT00493792 is a clinical study titled "X-3 Polyethylene Survival Outcomes Study". The goal of this clinical trial is to compare two types of polyethylene (Stryker Orthopaedics N2Vac and their X3 polyethylene) prostheses that are used in total knee replacements. The primary outcome will analyze whether or not prostheses require a revision surgery 10 years post knee replacement. Ot...
What is the current status of trial NCT00493792?
This trial is currently completed. It is a NA study. The enrollment target is 518 participants. The study started on 2007-02. Estimated completion is 2023-11-01.
What conditions does trial NCT00493792 study?
This clinical trial studies the following conditions: Arthroplasty, Replacement, Knee, Total Knee Replacement.
What interventions are being tested in trial NCT00493792?
The interventions under investigation include: X3 Polyethylene (DEVICE), N2Vac Polyethylene (DEVICE).
Who is sponsoring clinical trial NCT00493792?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00493792 being conducted?
This trial has 3 study locations across Arizona, Florida, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arthroplasty, Replacement, Knee
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00493792's enrollment target sits among peer trials
518 1st of 12 higher than 12 of 12 other Arthroplasty, Replacement, Knee trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Arthroplasty, Replacement, Knee trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Real-component Vs All-cement Articulating Spacers for Periprosthetic Knee Infection
RECRUITING · NA
-
A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery
RECRUITING · NA
-
TracPatch in Total Knee Arthroplasty
ACTIVE NOT RECRUITING · NA
-
Music Therapy Versus Control for Total Knee Arthroplasty
COMPLETED · NA
-
Traditional vs Oral Fluid Management in Total Knee Arthroplasty
COMPLETED · NA
-
Study to Evaluate ACB Versus FNB Early Postoperative Period Functional Outcomes After TKA
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04524871 · 518 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
- NCT07112196 · 518 participants · Phase 2
Visugromab in Cachexia International Trial
- NCT05676450 · 517 participants · NA
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
- NCT02323581 · 520 participants · NA
Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia